C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01) A61K 38/21 (2006.01) C12P 19/34 (2006.01) C12Q 1/00 (2006.01) G01N 33/53 (2006.01)
Patent
CA 2580299
Disclosed is a method of determining interferon responsiveness in a patient suffering from multiple sclerosis. The method comprises determining an amount of a XAF-1 gene expression level in a blood sample, which is obtained from the patient undergoing interferon therapy. The amount of the XAF-1 gene expression level in the blood sample is then correlated with the responsiveness of the patient to the interferon.
Bhan Virender
Hebb Andrea
Holcik Martin
Korneluk Robert G.
Moore Craig
Aegera Therapeutics Inc.
Children's Hospital Of Eastern Ontario
Fasken Martineau Dumoulin Llp
LandOfFree
Diagnostic marker for interferon responsiveness in multiple... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diagnostic marker for interferon responsiveness in multiple..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnostic marker for interferon responsiveness in multiple... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1928239